AEGiS-LT: Nobel Prize awarded for AIDS, cervical cancer research Los Angeles TimesImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Los Angeles Times main menu
DonateNow


Nobel Prize awarded for AIDS, cervical cancer research

Los Angeles Times - October 6, 2008
Thomas H. Maugh II, thomas.maugh@latimes.com


The awards recognize two French researchers who discovered the human AIDS virus and a German scientist who showed that human papilloma virus causes cervical cancer.

Two French researchers who discovered the human AIDS virus and a German scientist who showed that human papilloma virus causes cervical cancer were awarded on Monday the 2008 Nobel Prize in Physiology or Medicine.

The decision effectively ends the long-running dispute between France's Luc Montagnier and America's Dr. Robert Gallo, concluding that Montagnier and his colleague Francoise Barre-Sinoussi were the rightful discoverers of the virus, which is now carried by more than 33 million people worldwide.

The other half of the $1.4-million prize was awarded to Dr. Harold zur Hausen of the University of Dusseldorf for discovery of the viruses that cause genital warts and are responsible for an estimated 500,000 cases of cervical cancer each year.

"I'm not prepared for this," zur Hausen, 72, told the Associated Press. "We're drinking a little glass of bubbly right now."

Montagnier, 76, is now director of the World Foundation for AIDS Research and Prevention in Paris; Barre-Sinoussi, 61, is still at the Pasteur Institute in Paris, where the discovery was initially made. The award to them is the first Nobel received by a French scientist since 1980.

Barre-Sinoussi received word of the prize in Cambodia, where she is doing research, while Montagnier was in Abidjan, Ivory Coast, delivering a lecture.

Their work was honored, the Nobel citation said, because "never before has science and medicine been so quick to discover, identify the origin, and provide treatment for a new disease entity."

Montagnier and Gallo conducted a bitter public dispute over discovery of HIV in the 1980s, with each claiming that the other had misused viral samples.

At stake was not only scientific primacy for the discovery of the virus but millions of dollars in licensing fees from tests used to detect HIV infections in patients.

The dispute was so contentious that then- President Ronald Reagan and French Prime Minister Jacques Chirac eventually stepped in in 1987, negotiating an agreement that divided the royalties equally.

In the 1990s, however, the U.S. government conceded that France deserved the lion's share of the royalties, affirming Montagnier's role.

The Nobel citation did not mention Gallo's role, noting only that "after the discovery of the virus, several groups contributed to the definitive demonstration of HIV as the cause" of AIDS.

Gallo said Monday that he was "disappointed" by the foundation's rejection of his role.

Zur Hausen's work was far less controversial, although his proposal that human papilloma virus, commonly called HPV, causes cervical cancer was initially disparaged by other researchers.

But he reasoned that if the virus played such a role, its DNA would be incorporated into that of tumor cells, and he spent more than a decade looking for evidence of that incorporation. That search was complicated by the fact that only segments of the virus made it into the tumor DNA.

After a decade of searching, in 1984 he found that one strain, called HPV-16, was in some tumors. The following year, he showed that a second strain, HPV-18, was in others. He then cloned the two viruses and made them available to other researchers.

Those two strains are now known to cause an estimated 70% of all cases of cervical cancer and vaccines against them are now beginning to play a crucial role in preventing the disease.

A total of about 15 strains of the virus are now known to cause cervical cancer. The viruses have also been associated with penile, oral and other cancers as well.

The prizes will be presented in Stockholm on December 10.


081006
LT081003


Copyright © 2008 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053.  http://www.latimes.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .